John Tozzi

UnitedHealth Group Inc. board members ignored a raft of governance and oversight risks for years before catastrophic failures triggered billions in losses for investors, a shareholder lawsuit alleges.

Appeals work about half the time.

New data show how often insurers deny prior authorizations that can stall patients’ care — and how frequently those decisions get reversed.

(Bloomberg) -- Vice President JD Vance announced the Trump administration will take hundreds of thousands of people off Obamacare plans, alleging they were improperly enrolled.

Summit Therapeutics Inc. shares rose after it said AstraZeneca Plc would make a $2 billion strategic equity investment in the cancer drugmaker to jointly develop drugs.

UnitedHealth Group Inc. must defend itself against a slimmed-down lawsuit by a major shareholder that alleges investors were deceived about financial transactions that boosted earnings, a federal judge ruled.

Hinge Health Inc. expects to make more acquisitions, particularly in hardware, as part of a push to automate healthcare and expand beyond its core business of digital physical-therapy service.

Prime Therapeutics, one of the largest US pharmacy benefit managers, aims to shift to upfront drug pricing and away from a complicated rebates-based system that critics say increases patient costs.

The Michigan attorney general is suing the state's Blue Cross Blue Shield insurance plan for alleged anticompetitive conduct, opening a new front in a long-running legal fight over the structure of Blue Cross plans.

Surgery Partners will be acquired by an affiliate of Bon Secours Mercy Health for an enterprise value of $5.7 billion, and the surgery group’s private equity backer Bain Capital will continue to hold a stake in the new entity.